Literature DB >> 30905276

Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being.

Natasha L Mason1, Elisabeth Mischler2, Malin V Uthaug1, Kim P C Kuypers1.   

Abstract

Creative thinking and empathy are crucial for everyday interactions and subjective well-being. This is emphasized by studies showing a reduction in these skills in populations where social interaction and subjective well-being are significantly compromised (e.g., depression). Anecdotal reports and recent studies suggest that a single administration of psilocybin can enhance such processes and could therefore be a potential treatment. However, it has yet to be assessed whether effects outlast acute intoxication. The present study aimed to assess the sub-acute effects of psilocybin on creative thinking, empathy, and well-being. Participants attending a psilocybin retreat completed tests of creative (convergent and divergent) thinking and empathy, and the satisfaction with life scale on three occasions: before ingesting psilocybin (N = 55), the morning after (N = 50), and seven days after (N = 22). Results indicated that psilocybin enhanced divergent thinking and emotional empathy the morning after use. Enhancements in convergent thinking, valence-specific emotional empathy, and well-being persisted seven days after use. Sub-acute changes in empathy correlated with changes in well-being. The study demonstrates that a single administration of psilocybin in a social setting may be associated with sub-acute enhancement of creative thinking, empathy, and subjective well-being. Future research should test whether these effects contribute to the therapeutic effects in clinical populations.

Entities:  

Keywords:  Convergent thinking; creativity; divergent thinking; empathy; life satisfaction; psilocybin

Mesh:

Substances:

Year:  2019        PMID: 30905276     DOI: 10.1080/02791072.2019.1580804

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  13 in total

Review 1.  Modulation of Social Cognition via Hallucinogens and "Entactogens".

Authors:  Katrin H Preller; Franz X Vollenweider
Journal:  Front Psychiatry       Date:  2019-12-03       Impact factor: 4.157

2.  Spontaneous and deliberate creative cognition during and after psilocybin exposure.

Authors:  N L Mason; K P C Kuypers; J T Reckweg; F Müller; D H Y Tse; B Da Rios; S W Toennes; P Stiers; A Feilding; J G Ramaekers
Journal:  Transl Psychiatry       Date:  2021-04-08       Impact factor: 6.222

3.  Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality.

Authors:  Brandon Weiss; Victoria Nygart; Lis Marie Pommerencke; Robin L Carhart-Harris; David Erritzoe
Journal:  Front Psychol       Date:  2021-11-25

4.  A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.

Authors:  Marija Bogadi; Snježana Kaštelan
Journal:  Croat Med J       Date:  2021-10-31       Impact factor: 1.351

5.  The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.

Authors:  James J Rucker; Lindsey Marwood; Riikka-Liisa J Ajantaival; Catherine Bird; Hans Eriksson; John Harrison; Molly Lennard-Jones; Sunil Mistry; Francesco Saldarini; Susan Stansfield; Sara J Tai; Sam Williams; Neil Weston; Ekaterina Malievskaia; Allan H Young
Journal:  J Psychopharmacol       Date:  2022-01-04       Impact factor: 4.153

Review 6.  Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.

Authors:  Athanasios Markopoulos; Antonio Inserra; Danilo De Gregorio; Gabriella Gobbi
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

7.  Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.

Authors:  Keri Mans; Hannes Kettner; David Erritzoe; Eline C H M Haijen; Mendel Kaelen; Robin L Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

Review 8.  Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.

Authors:  Kristin Heuschkel; Kim P C Kuypers
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

Review 9.  Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy.

Authors:  Sascha B Thal; Stephen J Bright; Jason M Sharbanee; Tobias Wenge; Petra M Skeffington
Journal:  Front Psychol       Date:  2021-07-13

10.  The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Authors:  Malin Vedøy Uthaug; Alan K Davis; Trevor Forrest Haas; Dawn Davis; Sean B Dolan; Rafael Lancelotta; Christopher Timmermann; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2021-05-05       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.